ACT-16 THE POTENTIAL OF HYPOFRACTIONATED RADIOTHERAPY AND BEVACIZUMAB FOR GLIOBLASTOMA TREATMENT

INTRODUCTION: First-line bevacizumab (BEV) is now available as a treatment option for glioblastoma (GBM) patients with severe clinical conditions in Japan. However, the survival benefits remain controversial. As we have emphasized the combined effect of BEV and radiation therapy, the strategies; 1)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Adv
Main Authors: Hata, Nobuhiro, Mizoguchi, Masahiro, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Akagi, Yojiro, Amemiya, Takeo, Fujioka, Yutaka, Takigawa, Kosuke, Yoshitake, Tadamasa, Yoshimoto, Koji, Iihara, Koji
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213105/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.065
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados